Cisplatin 1 MG/ML Injectable Solution — RxCUI 309311
RxNorm drug concept · Semantic clinical drug
RxCUI 309311
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
23 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI309311
Official nameCisplatin 1 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascisplatin 50 MG per 50 ML Injectable Solution; cisplatin 100 MG per 100 ML Injectable Solution
FDA products mapped19
Package NDCs mapped23
Reported Medicaid activity (SDUD)15,526 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cisplatin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The fluids are there to protect your kidneys — one of cisplatin's most serious side effects is kidney damage, and staying well-hydrated helps flush the drug through your kidneys mo...
- Why do I need so much IV fluid before and after my cisplatin treatment?
- Cisplatin is one of the most strongly nausea-causing chemotherapy drugs there is — without prevention, almost everyone experiences severe nausea and vomiting. The good news is that...
- Will I definitely get sick to my stomach from cisplatin?
🕸️ Concept Web — How Cisplatin 1 MG/ML Injectable Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cisplatin 1 MG/ML Injectable Solution
RxCUI 309311 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cisplatin
2555IN
-
Cisplatin
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cisplatin Injectable Solution
376433SCDF -
Cisplatin Injectable Product
1152129SCDG -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Cisplatin Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cisplatin 1 MG/ML
328303SCDC
-
Cisplatin 1 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cisplatin 1 MG/ML
SCDC · 328303 -
Cisplatin Injectable Solution
SCDF · 376433 -
Cisplatin Injectable Product
SCDG · 1152129
📦 FDA Products & Package NDCs
19 products · 23 package NDCs
23 package NDCs map to RxCUI 309311 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9504-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0143-9504-01) / 50 mL in 1... | CISplatin | Hikma Pharmaceuticals USA Inc. | 2000-11-07 |
| 00143-9505-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0143-9505-01) / 100 mL in 1... | CISplatin | Hikma Pharmaceuticals USA Inc. | 2000-11-07 |
| 00703-5747-11 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5747-11) / 50 mL in 1... | Cisplatin | Teva Parenteral Medicines, Inc. | 2000-06-01 |
| 00703-5748-11 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5748-11) / 100 mL in 1... | Cisplatin | Teva Parenteral Medicines, Inc. | 2000-06-01 |
| 16729-0288-11 | 50 mL in 1 VIAL (16729-288-11) | Cisplatin | Accord Healthcare Inc. | 2016-12-13 |
| 16729-0288-38 | 100 mL in 1 VIAL (16729-288-38) | Cisplatin | Accord Healthcare Inc. | 2016-12-13 |
| 25021-0253-50 | 1 VIAL in 1 CARTON (25021-253-50) / 50 mL in 1 VIAL | Cisplatin | Sagent Pharmaceuticals | 2023-07-01 |
| 25021-0253-51 | 1 VIAL in 1 CARTON (25021-253-51) / 100 mL in 1 VIAL | Cisplatin | Sagent Pharmaceuticals | 2023-07-01 |
| 44567-0509-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (44567-509-01) / 50 mL in 1... | CISplatin | WG Critical Care, LLC | 2012-01-13 |
| 44567-0510-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (44567-510-01) / 100 mL in 1... | CISplatin | WG Critical Care, LLC | 2012-01-13 |
| 44567-0511-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (44567-511-01) / 200 mL in 1... | CISplatin | WG Critical Care, LLC | 2015-04-15 |
| 60505-6279-00 | 1 VIAL, MULTI-DOSE in 1 CARTON (60505-6279-0) / 50 mL in 1... | CISplatin | Apotex Corp. | 2024-09-13 |
| 63323-0103-51 | 1 VIAL in 1 CARTON (63323-103-51) / 50 mL in 1 VIAL | Cisplatin | Fresenius Kabi USA, LLC | 2000-09-05 |
| 63323-0103-64 | 1 VIAL in 1 CARTON (63323-103-64) / 200 mL in 1 VIAL | Cisplatin | Fresenius Kabi USA, LLC | 2000-09-05 |
| 63323-0103-65 | 1 VIAL in 1 CARTON (63323-103-65) / 100 mL in 1 VIAL | Cisplatin | Fresenius Kabi USA, LLC | 2000-09-05 |
| 68001-0283-27 | 1 VIAL in 1 CARTON (68001-283-27) / 50 mL in 1 VIAL (68001-... | Cisplatin | BluePoint Laboratories | 2016-08-02 |
| 68001-0283-32 | 1 VIAL in 1 CARTON (68001-283-32) / 100 mL in 1 VIAL (68001... | Cisplatin | BluePoint Laboratories | 2016-08-02 |
| 68001-0608-24 | 1 VIAL in 1 CARTON (68001-608-24) / 50 mL in 1 VIAL | CISPLATIN | BluePoint Laboratories | 2024-01-01 |
| 68001-0609-33 | 1 VIAL in 1 CARTON (68001-609-33) / 100 mL in 1 VIAL | CISPLATIN | BluePoint Laboratories | 2024-01-01 |
| 68083-0162-01 | 1 VIAL in 1 CARTON (68083-162-01) / 50 mL in 1 VIAL | CISPLATIN | Gland Pharma Limited | 2017-04-03 |
| 68083-0163-01 | 1 VIAL in 1 CARTON (68083-163-01) / 100 mL in 1 VIAL | CISPLATIN | Gland Pharma Limited | 2017-04-03 |
| 72266-0252-01 | 1 VIAL in 1 CARTON (72266-252-01) / 50 mL in 1 VIAL | CISPLATIN | FOSUN PHARMA USA INC | 2023-08-11 |
| 72266-0253-01 | 1 VIAL in 1 CARTON (72266-253-01) / 100 mL in 1 VIAL | CISPLATIN | FOSUN PHARMA USA INC | 2023-08-11 |
Observed labelers:
BluePoint Laboratories (4) ·
Fresenius Kabi USA, LLC (3) ·
WG Critical Care, LLC (3) ·
Accord Healthcare Inc. (2) ·
FOSUN PHARMA USA INC (2) ·
Gland Pharma Limited (2)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9060 | Cisplatin 10 mg injection | 19 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.